Download the Full Event Guide to See What You Missed:
- 20 expert speakers, including representatives from AbbVie, Janssen, Genentech and Bristol Myers Squibb
- The range of hot topics to be covered, including identifying new signatures for subtyping IBD, optimizing and accelerating diagnostic and prognostic technologies, uncovering novel therapeutic targets based on patient stratification and embracing artificial intelligence and non-invasive markers of IBD
- Unmissable workshops delving into the future of microbiome in IBD and how to achieve quality assurance when developing IBD markers
- Hear from the experts themselves on why this meeting is not to be missed!